Debut Plus

49.7

+0.18 +0.36%

17 Jul 2026

BSE Listed

EIKO Lifesciences Limited (540204)

Volume: 189Avg Vol 1W: 8,443Avg Vol 1M: 10,28352W Range:45.964.44
Market Cap₹71 Cr
Current Price₹49.7
Previous Close₹49.52
High / Low (52w)₹64.44 / ₹45.9
Volume189
Avg Vol (1W)8,443
Avg Vol (1M)10,283
Stock P/E15.88
Book Value₹47.94
Dividend Yield0%
ROE6.54%
ROA5.95%
Revenue (TTM)
Revenue Growth
Profit Margin8.54%
Total Debt
Shares Outstanding1 Cr
Face Value
EPS (TTM)₹3.13
P/B1.04
Debt / Equity0.05
50 DMA₹50.48
200 DMA₹51.81
Day change+0.36%
Price Chart
49.7 5.41% · 1Y
62481.2L
2025-07-17
2026-07-17

20-day avg volume: 11K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 269% YoY.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹11 Cr₹8 Cr₹7 Cr₹11 Cr₹11 Cr₹12 Cr₹12 Cr₹18 Cr
EBITDA₹0 Cr₹0 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr
EPS
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2025
Revenue₹2 Cr₹4 Cr₹10 Cr₹38 Cr
EBITDA₹0 Cr₹-1 Cr₹-5 Cr₹3 Cr
Net Profit₹0 Cr₹0 Cr₹-2 Cr₹2 Cr
EPS0.63-1.16-4.991.62
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2025
Total Assets₹11 Cr₹9 Cr₹12 Cr₹66 Cr
Total Liabilities₹5 Cr₹5 Cr₹11 Cr₹9 Cr
Equity₹6 Cr₹5 Cr₹1 Cr₹57 Cr
Total Debt
Cash Flow
MetricMar 2019Mar 2020Mar 2025
Operating₹0 Cr₹0 Cr₹3 Cr
Investing₹0 Cr₹-1 Cr₹-11 Cr
Financing₹-1 Cr₹1 Cr₹7 Cr
Free Cash Flow₹0 Cr₹0 Cr₹3 Cr
Shareholding
Promoter 39.91% Institutions 0% Public 60.09%
Efficiency & Working Capital
ROCE10.1%
Interest Coverage17
Dividend Payout
Debtor Days105 d
Inventory Days56 d
Payable Days32 d
Cash Conversion Cycle128 d
Working Capital Days160 d
Shareholding Details

As of 2026-03-31

Promoter39.9%
FII0%
DII0%
Institutions0%
Public60.1%
Promoter Pledge0%
No. of Shareholders2,969
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2024Sept 2024Nov 2024Dec 2024Jan 2025Mar 2025Jun 2025Aug 2025Sept 2025Dec 2025Feb 2026Mar 2026
Promoters24.4%24.4%31.3%31.3%31.3%36.2%36.7%37.1%37.2%37.2%39.9%39.9%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public75.6%75.6%68.7%68.7%68.7%63.8%63.3%62.9%62.8%62.8%60.1%60.1%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders2,9383,1403,1993,4563,5653,3363,3223,2033,1503,0923,0282,969
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Lenus Finvest Private LimitedShareholding of Promoter and Promoter Group17.7%25,40,472
Laxmikant Kabra (huf)Shareholding of Promoter and Promoter Group9.9%14,20,000
2b Black Bio LlpPublic Shareholding9.6%13,79,672
Bhavesh Dhirajlal TannaShareholding of Promoter and Promoter Group5.9%8,40,000
Siddhant Laxmikant KabraShareholding of Promoter and Promoter Group5.6%8,07,650
Ashika Global Finance Pvt. Ltd.Public Shareholding4.1%5,91,864
Ashok Vishwanath HiremathPublic Shareholding3.7%5,33,333
Kaushik DagaPublic Shareholding2.2%3,19,007
Sivanesan SellappanPublic Shareholding2%2,90,029
Joyanta Kumar JanaPublic Shareholding2%2,85,109
Sushila Paraskumar DagaPublic Shareholding1.7%2,38,806
Parshva Kumar DagaPublic Shareholding1.7%2,36,817
Bhavinkumar Vinaychand ShahPublic Shareholding1.4%1,94,237
Laxmikant Ramprasad KabraShareholding of Promoter and Promoter Group0.8%1,16,666
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Laxmikant Ramprasad Kabra00%2026-03-31
Bhavesh Dhirajlal Tanna00%2026-03-31
Siddhant Laxmikant Kabra00%2026-03-31
Laxmikant Kabra (huf)00%2026-03-31
Lenus Finvest Private Limited00%2026-03-31
Kaushik Daga00%2026-03-31
Sushila Paraskumar Daga00%2026-03-31
Parshva Kumar Daga00%2026-03-31
Bhavinkumar Vinaychand Shah00%2026-03-31
Joyanta Kumar Jana00%2026-03-31
Sivanesan Sellappan00%2026-03-31
Ashok Vishwanath Hiremath00%2026-03-31
Board of Directors
NameDesignationYear
Laxmikant KabraChairman & Non Executive Dir.2025
Bhavesh Dhirajlal TannaNon-Exec & Non-Independent Dir2025
Rajkumar K BahetiIndependent Non Exe. Director2025
Kajal Dhanpatraj KothariIndependent Non Exe. Director2025
Hasti DoshiIndependent Non Exe. Director2025
Sumukh Prabhakar VartakWhole-time Director2025
CHINTAN BHARATBHAI DOSHICompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10141414
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20258610016
2025801009
2025000000
Substantial Acquisitions (SAST)

30 disclosure(s)

Pref. Allotment24/02/2026 · 1,75,000
Pref. Allotment24/02/2026 · 4,50,000
Market25/06/2025 · 71,000
Market27/03/2025 · 1,30,000
Market25/03/2025 · 43,000
Market17/03/2025 · 47,000
Company Information
Incorporated1977
ChairmanLaxmikant Kabra
AuditorPSV Jain & Associates
Investor Email[email protected]
🌐 www.eikolifesciences.com

📍 1st Matru Chhaya Ground Floor, M Karve Road Naupada, Thane, Maharashtra, 400602

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search